Carmel Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Carmel Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-456	Closed	-$231K	–	642
2023 Q3	$231K	Buy	456 +234	+105%	+$125K	0.1%	138
2023 Q2	$116K	Sell	222 -252	-53%	-$136K	0.06%	159
2023 Q1	$273K	Sell	474 -112	-19%	-$63.1K	0.16%	104
2022 Q4	$322K	Sell	586 -20	-3%	-$10.6K	0.22%	92
2022 Q3	$307K	Buy	606 +2	+0.3%	+$1.12K	0.3%	80
2022 Q2	$328K	Hold	604	–	–	0.31%	76
2022 Q1	$357K	Sell	604 -6	-1%	-$3.45K	0.3%	76
2021 Q4	$407K	Buy	+610	New	+$381K	0.3%	68

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM